European Innovation Council

Astrape powers the future of datacenters: more bandwidth, less power.

PrecisionLife is a company focused on advancing precision medicine by leveraging its proprietary artificial intelligence platform to enhance the understanding of chronic diseases. It specializes in patient stratification, which allows for the identification of novel subgroups within patient populations, thereby generating insights that inform the discovery of new drug targets and drug repositioning candidates. By utilizing unique and patentable biomarkers, PrecisionLife connects patients with specific disease sub-groups and potential therapies, ultimately aiming to create personalized treatment alternatives. The company’s innovative approach not only drives advancements in biopharmaceuticals but also seeks to improve patient outcomes, enabling individuals to lead longer and healthier lives.

Stablepharma Ltd specializes in developing innovative processes for vaccine stabilization, focusing on its technology platform, StablevaX™, which transforms existing approved vaccines, therapeutics, and diagnostics into thermostable products that do not require refrigeration. This advancement addresses the global challenges associated with cold chain logistics, allowing for efficient and waste-free vaccine delivery. The company has identified up to 60 vaccine candidates suitable for its technology and collaborates with global vaccine manufacturers, academic institutions, and non-governmental organizations to enhance its pipeline of thermostable products. Founded in 2012 and based in Bath, United Kingdom, Stablepharma aims to reduce costs and carbon emissions while expanding access to vaccines for both children and adults.

Deeploy is a developer of a machine learning operations platform focused on enhancing the accountability and transparency of AI systems. The platform centralizes explainable AI (XAI) within machine learning operations (MLOps), empowering users to comprehend how models function and to rectify automated decisions when necessary. By organizing deployments, tracking model performance, generating trace logs, and facilitating the creation of custom models and explainers, Deeploy provides data scientists and users with the tools needed to understand the implications and applications of machine learning models. This approach ensures that AI systems are both trustworthy and accountable.

MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.

AlzeCure Pharma AB, established in 2012 and headquartered in Huddinge, Sweden, is a pharmaceutical company dedicated to developing drug therapies for central nervous system disorders. The company's primary focus is on Alzheimer's disease, with a pipeline consisting of five drug candidates based on its NeuroRestore and Alzstatin research platforms. These candidates are in various stages of development, targeting conditions such as sleep disruptions, traumatic brain injuries, neuropathic pain, and eye/ear indications. AlzeCure's team comprises key professionals with complementary expertise, spanning from molecule to man, and the company aims to be an industry-standard incubator for novel projects.

QDI Systems B.V. is a startup based in Groningen, the Netherlands, specializing in the development of advanced imaging devices for medical applications using quantum dot technology. The company focuses on creating X-ray sensors that deliver high-contrast and high-resolution mammograms, allowing for improved diagnostic capabilities while minimizing radiation exposure for patients. QDI Systems emphasizes user-friendliness by providing accessible quantum dot materials along with comprehensive instructions for constructing high-performance imaging devices. This approach enables healthcare professionals to obtain precise medical images, enhancing the overall efficacy of diagnostic procedures.

Elicera Therapeutics is a clinical-stage immuno-oncology company based in Sweden, focused on developing innovative cell and gene therapies for cancer treatment. The company’s portfolio includes four drug candidates: ELC-100 and ELC-201, which are oncolytic virus therapies, and ELC-301 and ELC-401, which are CAR T-cell treatments. Additionally, Elicera has developed a universal CAR T-cell technology platform known as iTANK (ELC-001), designed to enhance the effectiveness of CAR T-cell therapies by enabling a multi-targeted approach against solid tumors.

Photon IP is a deeptech startup located in Eindhoven, the Netherlands, focused on developing advanced technologies for photonics applications. The company specializes in application-specific semiconductors that cater to various sectors, including wearable electronics and data centers. By providing innovative solutions, Photon IP supports clients in industries such as automotive and telecommunications, aiming to enhance the functionality and efficiency of their products.

AQLAS is shaping the quantum future and discovering Next-Gen Lasers redefining quantum computing. Our high-quality hardware is set apart by its economical, compact, and efficient nature, thus paving the way for the proliferation of quantum computers.

Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).

Quantune is a deep tech startup specializing in optics and photonics technology. The company develops a compact infrared spectrometer that miniaturizes traditional laboratory equipment for molecular analysis, making it accessible for both biomedical consumer devices and industrial applications. This innovative spectrometer facilitates continuous and non-invasive health monitoring, allowing clients to achieve real-time monitoring and analysis of chemical compounds and emissions. By transforming large-scale laboratory processes into a portable module, Quantune enables novel applications in various fields, enhancing the capabilities of health and environmental monitoring.

AISPECO is a Lithuanian company that specializes in geospatial monitoring systems for various types of vehicles, including helicopters, planes, unmanned aerial vehicles (UAVs), and terrestrial vehicles. The company develops aerial inspection systems specifically designed for conducting powerline surveys using helicopters and drones. Its platform is capable of capturing multiple types of imagery, such as optical, infrared, corona, and hyperspectral, which enhances the efficiency and effectiveness of infrastructure inspections. By focusing on advanced imaging technology, AISPECO enables clients to perform inspections with greater endurance and scalability in their operations.

Turing College operates as an online educational institution specializing in data science. It offers courses suitable for individuals of varying skill levels and employs an income share agreement model, allowing students to defer payment until they secure employment. The college collaborates with tech companies to co-create its curriculum, providing these partners with real-time student performance updates to facilitate expedited hiring decisions.

Maynooth University is internationally recognised for quality and value of Their research and scholarship and Their dedication and commitment to teaching and Their students. Part of the NUI and formally established as an autonomous university in 1997, Maynooth University traces its origins to the foundation of the Royal College of St. Patrick in 1795, drawing inspiration from a heritage that includes over 200 years of education and scholarship. The University is a place of lively contrasts. It is a modern institution, dynamic, rapidly-growing, research-led and engaged, yet grounded in historic academic strengths and scholarly traditions.

Hideez is a cybersecurity company that specializes in manufacturing hardware and providing services for secure authentication. Based in the USA and Ukraine, the company offers the Hideez Key, a hybrid device combining wireless authentication, password management, and access control for both physical and digital environments. This multifunctional key uses encrypted Bluetooth, RFID, and NFC technologies, and supports various authentication standards, making it a versatile and secure solution for managing user credentials.

Ephos specializes in the development of integrated photonic circuits utilizing glass technology to improve computing capabilities. The company aims to minimize signal loss, facilitating innovative designs for both classical and quantum applications. By employing a proprietary manufacturing process, Ephos produces high-quality circuits tailored to the specific requirements of clients in the computational infrastructure sector. Their products are particularly suited for use in quantum computing, quantum communications, and quantum sensing, enabling customers to create scalable quantum infrastructures.

Oryl Photonics specializes in developing laboratory instruments for pharmaceutical and biotech companies. Their core product provides a simple, reliable, and cost-effective method for measuring solubility, contributing to accelerated drug development and improved medicine. The company's unique technology preserves valuable substances during testing, offering a solubility measurement service that empowers researchers to make data-driven decisions and expedite product development.

MediWound Ltd. is a biopharmaceutical company that specializes in the development, manufacturing, and commercialization of innovative therapeutic products aimed at addressing unmet medical needs, particularly in the areas of severe burns and chronic wounds. Founded in 2000 and headquartered in Yavne, Israel, it markets NexoBrid, a biopharmaceutical agent designed for the removal of eschar, or dead tissue, in patients with severe burns. NexoBrid has completed clinical development and is approved for use in Europe. The company is also advancing other products in its pipeline, including EscharEx, which has completed Phase II clinical trials for the debridement of chronic wounds, and MWPC003 for connective tissue disorders. MediWound aims to improve patient outcomes and reduce the complications associated with traditional surgical interventions in wound management.

Bank of Memories operates a digital platform for long-term preservation of personal data, enabling users to store and organize various forms of digital memories, such as photos, videos, and documents. The platform employs blockchain technology and decentralized storage to ensure data security and longevity, allowing individuals and families to pass on their memories across generations. It offers features like dedicated data rooms for secure storage, an explorer tool for navigating stored information, and a whitepaper detailing the platform's technology.

King's College London (informally King's or KCL) is a public research university located in London, United Kingdom, and a constituent college of the federal University of London. King's is arguably the third-oldest university in England, having been founded by King George IV and the Duke of Wellington in 1829, receiving its royal charter in the same year. St Thomas' Hospital, which is now a teaching hospital of King's College London School of Medicine, has roots dating back to 1173. In 1836, King's became one of the two founding colleges of the University of London. King's is based in the centre of London and organised into nine academic schools, spread across four Thames-side campuses in central London and another in Denmark Hill in south London. It is one of the largest centres for graduate and post-graduate medical teaching and biomedical research in Europe; it is home to six Medical Research Council centres for <a href="https://www.dissertationcorp.co.uk/">dissertation help</a> , the most of any British university, and is a founding member of the King's Health Partners academic health sciences centre. King's has around 25,000 students and 6,113 staff and had a total income of £587 million in 2012/13, of which £164 million was from research grants and contracts. King's is a world-leading university, currently ranked 19th in the world (6th in the UK and 8th in Europe) in the 2013 QS World University Rankings, and 38th in the world (6th in the UK and 9th in Europe) in the 2013 Times Higher Education World University Rankings. There are currently 12 Nobel Prize laureates amongst King's alumni and current and former faculty. King's is a member of the Association of Commonwealth Universities, the European University Association, the Russell Group and Universities UK. It forms part of the 'golden triangle' of British universities.

ProFuse Technology specializes in advancing cultured meat production by enhancing methods and efficiency. The company has developed innovative technology that significantly reduces production time while improving meat quality and increasing yields. By accelerating muscle fiber growth, ProFuse enables meat producers to enhance their production capacity and lower costs, making cultured meat more accessible and sustainable.

Riverlane is a business focused on developing quantum computing software and engineering instruments to enhance the performance of quantum computers. The company collaborates with quantum computer manufacturers to create essential hardware and software tools that address the challenges posed by unstable qubits and system defects. By designing an ultra-low latency quantum operating system, Riverlane accelerates quantum-classical hybrid algorithms, thereby advancing hardware research and development. Their algorithms are specifically engineered to optimize the utilization of the complete quantum computing stack, helping hardware partners mitigate the system errors that currently hinder the effectiveness of quantum computers. Through these innovative solutions, Riverlane aims to transform experimental quantum technologies into viable commercial products.

Vitestro is a company focused on enhancing patient care through innovative autonomous blood drawing technology. It develops medical robotic devices tailored for use in hospitals and clinical laboratories. The company’s key product utilizes multi-dimensional ultrasound to detect nerves and arteries, leveraging deep learning to minimize the risk of arterial complications during blood draws. This advanced technology not only aids healthcare professionals in performing procedures with greater precision but also aims to improve overall patient health outcomes by reducing complications associated with traditional blood collection methods.

Dronamics is a developer of advanced unmanned aerial systems aimed at transforming airfreight logistics. By creating a new type of small, unmanned cargo airplane that is highly fuel-efficient, Dronamics aims to democratize shipping in emerging markets. The aircraft can transport payloads of 350 kilograms over distances of 2,500 kilometers at costs significantly lower than traditional air transport, reducing shipping expenses by over 50%. Designed for autonomous flight, the aircraft can be remotely monitored and managed via satellite, making it suitable for challenging delivery scenarios, including remote and mountainous regions. As the first and only Strategic Partner for drones recognized by IATA, Dronamics is positioned to make a substantial impact in the commercial logistics sector.

RS Research is a clinical-stage biotechnology company based in Istanbul, Turkey, focused on developing innovative nanomedicines for targeted cancer therapies. Founded in 2015, the company has established a proprietary drug delivery platform, Sagitta®, which enables the design of targeted drug candidates for various indications. RS Research's pipeline includes several proprietary programs in different stages of preclinical and clinical development, with its lead candidate, RS-0139, currently undergoing Phase I clinical trials in oncology patients. In addition to drug development, RS Research offers a range of services, including preclinical absorption, distribution, metabolism, and excretion studies, bioanalytical and analytical testing, and patent consulting. The company operates a GMP-certified production facility for clinical batch drug candidates and has successfully engaged in co-development projects with international partners, showcasing its commitment to advancing cancer treatment through modern therapeutic approaches.

Smart Farm Robotix specializes in manufacturing agricultural robots that tackle the challenges of manual weeding, herbicide use, and machine weeding. Their robots provide a cost-effective, reliable, and fully automated solution, equipped with innovative weed detection and elimination technology. This enables farmers to cultivate crops more efficiently and sustainably, while reducing dependence on manual labor and harmful chemicals.

Wavess is an innovative predictive marketing analytics platform that utilizes advanced AI technologies to help businesses forecast the success of their marketing campaigns prior to launch. The platform combines AI algorithms with behavioral science to offer personalized recommendations, ultimately enhancing engagement and conversion rates. Targeting digital marketing agencies, scale-ups, and enterprises in sectors such as fintech, retail, and technology, Wavess provides critical insights into audience preferences and effective customer segmentation. Its distinctive features, including pre-launch prediction and ideal customer profiling, are designed to optimize campaign outcomes and facilitate tailored marketing strategies. In addition, the platform analyzes audience demographics and campaign seasonality to create customized posting schedules and identify valuable leads within a company's network, further improving overall campaign performance.

RespiQ is a healthtech startup that specializes in portable, non-invasive breath analysis technology aimed at the early detection and management of respiratory diseases. By utilizing advanced emission spectroscopy and artificial intelligence, RespiQ's device identifies volatile organic compounds (VOCs) in breath, enabling real-time detection of conditions such as COPD exacerbations. The company's focus on affordability, portability, and user-friendliness seeks to democratize access to advanced diagnostics, ultimately improving patient outcomes and reducing healthcare costs. In addition to respiratory diseases, RespiQ's versatile platform has potential applications for asthma, lung cancer, and infectious diseases. The company also offers an app that provides personalized health insights and dietary guidance, allowing users to monitor their health proactively. RespiQ's combination of technical and healthcare expertise positions it as a leader in breath diagnostics, with a commitment to enhancing overall health and well-being.

Efenco is a cleantech startup focused on enhancing the energy conversion efficiency of industrial furnaces and boilers while minimizing their carbon emissions. The company has developed a patented product known as the high-energy ray ceramic chip (HERC), which can reduce carbon dioxide emissions and fuel costs by at least 18% across various energy-intensive sectors, including electricity generation, steel manufacturing, and cement production. Efenco employs principles from quantum and plasma physics, nanotechnology, and electrochemistry to revolutionize the management of waste heat generated from natural gas combustion. By converting waste heat into ionizing radiation through low-temperature plasma generation, Efenco provides industries with innovative solutions to optimize energy usage and improve thermal conversion efficiency, contributing to a more sustainable industrial landscape.

NEOGAP Therapeutics is a clinical-stage biopharmaceutical startup focused on immuno oncology. Their pharmaceutical product, personalized tumor trained lymphocytes, offers even one customized cell treatment that is meant to precisely target and destroy cancer in a tailored environment, with very minor side effects.

Acorai is developing a non-invasive heart failure monitoring platform centered on direct intracardiac pressure monitoring (ICPM). The company utilizes a patented combination of sensor technologies and machine learning to provide accurate and cost-efficient heart failure care. This innovative approach allows for non-invasive monitoring of cardiac and pulmonary pressure, which is crucial for improving outcomes in heart failure patients. By analyzing pressure dynamics through acoustic, vibratory, and waveform data, the device enables healthcare professionals to proactively adjust medications, potentially reducing re-hospitalization and mortality rates associated with heart failure. Clinically validated and designated as an FDA Breakthrough Device, Acorai's product is expected to enter the market in 2025.

Skytree is a company focused on developing innovative solutions for carbon dioxide capture and recycling. Founded in 2014, it leverages over a decade of research originally aimed at addressing CO2 challenges for astronauts on the International Space Station. Skytree specializes in direct air capture (DAC) technology that efficiently extracts carbon dioxide from ambient air. This technology supports a circular carbon supply, enabling businesses that need CO2 for their operations to reduce reliance on fossil fuels. By providing a reliable source of usable carbon dioxide, Skytree contributes to the transition toward a more sustainable future and a healthier planet. The company boasts a diverse team of skilled scientists, engineers, and business professionals, all guided by an experienced management team.

ResoTher Pharma is a Copenhagen-based biotechnology company specializing in the development of peptide-based drugs aimed at treating cardiovascular and inflammatory disorders characterized by neutrophil-driven inflammation. The company focuses on leveraging the endogenous immunomodulator Annexin A1 to create therapeutic solutions that act as resolution therapy for diseases associated with innate immune activation. By targeting a specific G-protein coupled receptor on leukocytes, ResoTher Pharma's patented peptide drugs aim to mimic the body's natural mechanisms for resolving inflammation and promoting tissue healing, addressing significant unmet medical needs in the treatment of these conditions.

RAIKU is a cleantech startup that produces 100% natural packaging material that has also great looks and shock absorption - most importantly, it gives 15-20 times more volume to its raw material making it one of the most resource efficient material uses in the world with high margins. Both the production is and products are clean making no harm to nature. RAIKU has raised over 1.2mln€ in the pre-seed stage, built a team of over 10 people, its own IP and clients are already using its packaging material. This material will up-end the 1 trillion € packaging sector.

SolasCure Limited is a biotechnology company based in Wales, United Kingdom, focused on developing innovative solutions for patients with chronic wounds. Founded in 2017, the company is advancing its product Aurase, a hydrogel designed to facilitate wound debridement by removing dead, damaged, or infected tissue to enhance healing. Aurase incorporates a recombinant enzyme derived from maggots, leveraging biomimicry and evidence-based medicine to improve wound care outcomes. SolasCure aims to provide effective wound bed preparation across various healthcare settings, ultimately accelerating the healing process for individuals suffering from chronic wounds.

VSORA is an intellectual property provider based in France, specializing in digital signal processing (DSP) technology for chipmakers focused on next-generation digital communications systems, particularly 5G networks. Established in 2015 by a team of experienced DSP engineers, the company offers a powerful multi-core DSP architecture that eliminates the necessity for DSP co-processors, thereby enhancing design flexibility. VSORA's innovative DSP development flow enables collaboration between signal processing engineers and software engineers, allowing them to work within the same environment and share source code, which significantly accelerates the time-to-market for new products. The company's mission is to address technical challenges by optimizing DSP computing power while minimizing power consumption and silicon footprint, thereby improving overall system performance.

Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.

Swisspod Technologies SA is a transport development firm based in Monthey, Switzerland, founded in 2019. The company focuses on designing and developing Hyperloop vessels, which are tube-based transportation systems aimed at providing sustainable and efficient high-speed travel. Swisspod leverages high-quality Swiss engineering to create fully-electric Hyperloop pods that promise scalable and rapid transit between distant cities. The firm emphasizes energy efficiency and economic viability in its innovations, making its capsules both affordable and environmentally friendly. With a team of multidisciplinary experts, Swisspod is dedicated to transforming high-speed travel through its cutting-edge technology.

UPMEM is a fabless semiconductor company focused on enhancing the performance of data-intensive algorithms through its innovative Processing-In-Memory (PIM) solution. This technology addresses the limitations of traditional server architectures, which are hindered by data movement inefficiencies. By deploying a large number of programmable co-processors close to the data, UPMEM's platform accelerates performance for analytics and artificial intelligence applications by more than ten times. This unique approach not only improves computational speed but also reduces energy consumption and hardware footprint in data centers, making it an attractive solution for major application developers and cloud service providers.

INBRAIN Neuroelectronics is a medical device company based in Barcelona, Spain, that specializes in developing graphene-based neural interfaces and intelligent neuromodulation systems aimed at treating brain disorders. Founded in 2019, the company offers the world's first brain-computer interface (BCI) therapeutics platform, which integrates precise BCI decoding with micrometric modulation to provide adaptive and personalized treatments for conditions such as Parkinson's disease, epilepsy, and stroke rehabilitation. Its technology enables continuous real-time monitoring and autonomous adjustments to therapy, enhancing therapeutic outcomes while reducing side effects. INBRAIN is also engaged in strategic collaborations, including with Merck KGaA, to expand its innovative solutions into peripheral nerve and systemic disease applications, thereby advancing the field of neurotechnology and bioelectronics.

Pulse is a platform for furthering our understanding of bioprinting and its applications in space exploration and medicine.

Wooptix S.L., founded in 2014 and headquartered in Madrid, Spain, specializes in advanced imaging technologies. The company develops light field and wavefront phase imaging software that captures comprehensive information about light, utilizing the full resolution of sensors. This innovative platform allows for three-dimensional modulation of images across various camera setups, producing volumetric images and videos with enhanced data points and high frame rates. By focusing on improving human interaction with the environment, Wooptix aims to redefine the way users perceive and engage with their surroundings, offering new possibilities for image quality and post-processing capabilities.

Elgan Pharma is a biotechnology company specializing in neonatology, dedicated to addressing medical challenges and developmental issues faced by premature infants. The company is focused on developing innovative therapies utilizing nanotechnology to prevent visual impairment, a common and multifactorial problem in preterm babies. By targeting the specific needs of this vulnerable population, Elgan Pharma aims to enhance visual outcomes and reduce the risk of significant disabilities, ultimately supporting healthcare professionals in their efforts to improve the quality of life for these infants.

Aviwell is focused on creating healthy, natural, and sustainable solutions aimed at enhancing animal health and growth, thereby contributing to global nourishment. The company operates a microbiota-based discovery platform that leverages artificial intelligence and machine learning to bridge digital and life sciences. By developing innovative food products, Aviwell seeks to provide valuable insights into animal health, growth, and performance, ultimately supporting the agri-food industry in its efforts to sustainably meet the needs of a growing population.

Twinsity provides a platform designed for visualizing and inspecting high-resolution drone data and digital twins, facilitating collaboration throughout the infrastructure inspection process. The company's software integrates a comprehensive image database, enabling stakeholders to communicate, document, and inspect structures and assets more efficiently. By centralizing all relevant information, Twinsity enhances the management of infrastructure lifecycles and supports improved decision-making with the aid of artificial intelligence.

Cellbox Solutions is a technology company that specializes in innovative logistical solutions for the global BioMed industry. The company has developed a carbon dioxide incubator aimed at enhancing the storage, isolation, handling, and analysis of biological materials. This incubator supports the proper management of living cells, facilitating their storage, reproduction, transportation, and analysis. By enabling the safe transport of living cells via roads, rails, or airways, Cellbox Solutions assists healthcare providers in their efforts to deliver advanced therapies and improve patient treatment outcomes.

Woodio is a design-oriented company that specializes in innovative material technology for bathroom applications. The firm has developed a fully waterproof wood composite made from real wood chips, allowing for a range of design options while prioritizing sustainability. This technology offers customers fully recyclable biomaterials, enabling them to enhance and redesign their bathrooms with eco-friendly solutions. Woodio's focus on combining aesthetics with functionality positions it as a unique player in the market for bathroom design materials.

Escala Medical is focused on developing a minimally invasive medical device aimed at treating pelvic organ prolapse (POP) in women. The company's innovative system offers a nonsurgical, incision-free, and mesh-free repair option that addresses the vaginal apex by connecting it to the sacrospinous ligament. This approach is designed to be safe, quick, and to preserve organ functionality while minimizing patient discomfort. The procedure can be performed in outpatient and office-based settings, providing a much-needed alternative for women suffering from POP.

Cupffee specializes in the production of edible and biodegradable coffee cups and stirrers, offering a sustainable alternative to traditional disposable cups. Their manufacturing process is environmentally friendly, generating no industrial waste and only producing clean steam along with the pleasant aroma of freshly baked cookies. Additionally, any leftover materials from the cup production are repurposed as ingredients for other edible products, further enhancing their commitment to sustainability. Unlike conventional disposable cups, Cupffee's products decompose within days, allowing consumers to dispose of them in an environmentally responsible manner.

The Intelligence Behind Global Circularity VCG.AI transforms industrial by-products and waste into valuable resources. AI-powered development of circular economy business models with the latest technology, material, market, and regulatory insights. Their proprietary AI solution, the Value Chain Generator®, helps companies, cities, and regions accelerate the transition to a circular economy, through Valorisation of By-products and Waste, Circular Product Development, Regional Circular Opportunities Assessment. When organisations want to better valorise by-products and waste, develop or source circular materials, or enhance circularity in their value chains, VCG.AI analyses thousands of data points to deliver the optimal solution tailored to their specific needs and locations. What once took months or years can now be achieved in just weeks—without the need to hire additional technology or bioeconomy experts. VCG.AI’s ever-expanding system includes: - 650+ validated circular solutions - 150+ different proven valorisation technologies - 3.5 M companies - 4M tons of project-ready organic residuals across Europe VCG.AI is on a mission to accelerate the transition to a circular economy by unlocking circular opportunities for businesses worldwide. Learn more about them at www.vcg.ai.

3DSecret is developing cutting-edge technologies to uncover the stochastic patterns behind metastasis in order to predict the course of cancer.

Norbite is a biotech research firm focused on converting plastic waste into sustainable products through an innovative insect-based biorefinery. The company's technology integrates biorefinery and vertical farming methods to process plastic waste, yielding larvae that are bio-refined into proteins suitable for food and feed applications. By offering sustainable solutions, Norbite aims to contribute positively to environmental efforts while providing clients with valuable products and services.

Agurotech specializes in developing soil sensing technology designed to enhance agricultural practices. The company's offerings include reliable sensing devices and tailored irrigation recommendations that help farmers optimize water usage and nutrients. By leveraging Internet of Things applications, Agurotech enables data-driven farming, allowing agricultural and horticultural producers to improve decision-making and increase productivity. Their focus on continuous improvement in the irrigation process aims to save natural resources while providing farmers with actionable insights for more effective resource management.

Inobiostar focuses on research and experimental development services.

Naco Technologies Ltd, established in 2009 and headquartered in Riga, Latvia, specializes in the development, manufacturing, and supply of nano-coating technologies. The company offers a range of high-performance, multilayer and multicomponent coatings designed to enhance the durability and efficiency of equipment across various industries, including tooling, automotive, aerospace, and micro-chip manufacturing. These coatings, which include oil-enhanced, wear-protective, thermal barrier, and liquid-repellent varieties, are applied to client-supplied parts, creating ready-to-use coated components. In 2015, Naco Technologies was acquired by the Germany-based Schaeffler Group, further expanding its global reach and resources.

Samplix is a biotechnology company based in Herlev, Denmark, focused on single-molecule sample preparation for DNA and RNA. It has developed the Xdrop™ technology, which utilizes a unique “water-oil-water” droplet system to create millions of reaction chambers for handling individual DNA molecules. This innovative approach allows for targeted enrichment of large DNA fragments and enables researchers to sequence specific genetic regions effectively. Samplix's technology addresses the limitations of existing multi-molecule preparation methods, providing enhanced precision and sensitivity while simplifying the sample preparation process. Its solutions empower scientists to make informed research decisions, particularly in applications related to virus integration and CRISPR editing.

Smart Immune is a clinical-stage biotechnology company focused on developing innovative hematopoietic stem cell-based therapies aimed at improving the prognosis and quality of life for patients with serious diseases. The company's primary program utilizes T cell progenitors, known as ProTcells, which are designed to facilitate a rapid and safe immune recovery following transplantation. This therapy seeks to provide a polyclonal immune response, enhancing the body's ability to combat cancers and infections. Additionally, Smart Immune plans to complement its core offerings with advancements in targeted conditioning, gene therapy, and genome editing, thereby creating next-generation treatments for a range of inherited blood disorders and hematological malignancies.

Nemysis Limited is a specialty pharmaceutical company based in Dublin, Ireland, founded in 2005. The company focuses on addressing unmet needs in nutritional disorders and deficiencies through a staged approach to product development. Nemysis manufactures food supplements, medical matrix products, and prescription items, targeting the same conditions across different market segments. Among its innovative offerings are a gastric and trypsin-resistant glutenous product for oral enzymatic therapy aimed at celiac disease patients, as well as an iron supplement designed to minimize gastrointestinal side effects associated with iron supplementation. Additionally, the company is developing a glutenous medical device that effectively destroys gluten, helping to prevent symptoms in individuals with celiac disease and non-celiac gluten sensitivity.

Inbiome is a biotechnology company specializing in molecular diagnostics. It has developed proprietary molecular culture technology that accelerates bacterial testing and microbiome analysis. The company aims to advance clinical microbiology by focusing on microbial detection and product development, enabling more accurate and timely diagnoses, and ultimately improving patient outcomes.

Quantune is a deep tech startup specializing in optics and photonics technology. The company develops a compact infrared spectrometer that miniaturizes traditional laboratory equipment for molecular analysis, making it accessible for both biomedical consumer devices and industrial applications. This innovative spectrometer facilitates continuous and non-invasive health monitoring, allowing clients to achieve real-time monitoring and analysis of chemical compounds and emissions. By transforming large-scale laboratory processes into a portable module, Quantune enables novel applications in various fields, enhancing the capabilities of health and environmental monitoring.

Miwa is a retail solution provider focused on minimizing single-use packaging through a circular economy strategy. The company offers a system that includes reusable containers designed to reduce waste and promote sustainability. These sealable and reusable containers work alongside electronic dispensers located in retail environments, facilitating the bulk distribution of both food and non-food products. By enabling producers and retailers to store and dispense items in a hygienic manner, Miwa aims to create a more efficient and environmentally friendly approach to retail.

Molecular Attraction is a research and development firm focused on creating innovative solutions for vector-borne disease control and eradication. The company specializes in identifying biological compounds that can modify the behavior of vector organisms, including mosquitoes, ticks, flies, and rodents. By utilizing sustainable technology and chemical blends, Molecular Attraction aims to provide effective, long-lasting, and low-maintenance strategies for managing pest populations. Their approach not only enhances the effectiveness of pest control measures but also promotes environmentally friendly practices, contributing to a more cost-effective solution for combating vector-borne diseases.

GrayMatters Health is a health technology company focused on developing digital therapeutics aimed at addressing mental disorders through the regulation of brain processes. By utilizing an approach grounded in neuroscience, the company provides solutions that enhance the efficacy, safety, and accessibility of mental healthcare. Their offerings empower healthcare professionals and patients alike, enabling individuals with neurological disorders to manage their conditions more effectively and conveniently. GrayMatters Health aims to bridge existing gaps in mental health treatment, promoting better outcomes for those affected by these challenges.

Qurv, established in 2020, specializes in developing advanced image sensor technologies and integrated solutions. The company's core business is enabling next-generation computer vision applications, catering to the growing demands of autonomous and intelligent systems. Qurv's innovative technology, built on over eight years of research, leverages current CMOS manufacturing and advanced materials to deliver high-performance, reliable, and functional solutions for XR devices, service robots, and automotive industries.

IDloop specializes in biometric technology, focusing on contactless fingerprint sensor solutions tailored for both business and government markets. The company’s innovative technology captures secure three-dimensional images of multiple fingers, which significantly reduces false acceptance rates and enhances overall security. By leveraging advanced 3D imaging, artificial intelligence, and embedded technology, IDloop aims to provide efficient and reliable biometric identification, addressing the growing demand for secure access solutions in various sectors.

Valo Therapeutics is an immunotherapy company based in Oxford, United Kingdom, with an additional office in Helsinki, Finland. Founded in 2016, the company focuses on developing antigen-coated oncolytic viruses as therapeutic vaccines for cancer treatment. Its primary platform, PeptiCRAd, is an engineered human oncolytic adenovirus designed to stimulate a systemic anti-tumor T cell response. This innovative approach enables the conversion of oncolytic adenoviruses into targeted, tissue-specific cancer vaccines without the need for multiple genetically modified viruses. Additionally, Valo Therapeutics is working on other strategies, such as PeptiENV, to enhance therapeutic responses to enveloped oncolytic viruses across various cancer types. By utilizing tumor-specific peptides, the company aims to elicit a robust adaptive immune response, potentially providing lasting immunity against multiple cancers and improving patient outcomes.

TILT Biotherapeutics Ltd is a preclinical stage biotechnology company based in Helsinki, Finland, specializing in the development of genetically modified oncolytic viruses aimed at enhancing cancer treatments. The company's patented technology focuses on using these viruses to improve tumor T-cell therapies, including tumor-infiltrating lymphocyte (TIL) and chimeric antigen receptor (CAR-T) therapies, as well as checkpoint inhibitors. TILT Biotherapeutics is recognized as a leader in the global market for integrating oncolytic viruses with cancer immunotherapy. Their product pipeline includes TILT-123, TILT-234, and TILT-321, which are designed to modify the tumor microenvironment and counteract its suppression of immune responses. The innovative approach has the potential to replicate the successes seen in CAR-T therapy for solid tumors, similar to those achieved in hematological cancers.

ReLearn is a startup focused on leveraging artificial intelligence to assist companies and municipalities in minimizing their environmental impact by monitoring waste production. Utilizing a plug-and-play sensor called NANDO, which is installed on trash bins, ReLearn gathers precise data on the quantity and quality of waste generated daily. This data facilitates the creation of detailed sustainability reports and enhances awareness of environmental issues among corporate and civic stakeholders. The company employs gamification techniques to engage users and promote environmentally responsible behaviors. ReLearn aims to support visionary organizations in achieving their ZERO WASTE goals and adhering to key Sustainable Development Goals. By transforming ordinary bins into smart waste management systems, ReLearn enables clients to automate processes and improve efficiency while reducing carbon emissions and operational costs associated with improper waste disposal. The company has garnered recognition for its innovative approach, being a winner of the European Social Innovation Competition in 2022.

Efficient Energy Technology makes renewable energy simple, safe, and dependable for everyone. Efficient Energy Technology develops a small power plant consisting of photovoltaic and storage for complete self-installation.

Sostre Cvic is a non-profit organization that promotes an alternative model of housing access under the scheme.

Kvantify, founded in 2022 and headquartered in Copenhagen, Denmark, specializes in quantum computing management software aimed at addressing complex computational challenges across various sectors, including life sciences, financial services, and logistics. The company's platform focuses on enhancing drug discovery processes by employing proprietary physics-based methods to improve the quality of compounds tested in laboratories. By providing advanced computational drug technology, Kvantify enables life sciences companies to accelerate small molecule research and obtain actionable results that significantly impact their operations.

Iris.ai offers an AI-powered science assistant designed to enhance the efficiency of research and development departments by facilitating the navigation of scientific literature. Its primary product, RSpace, features advanced search capabilities, smart filters, reading list analysis, auto-generated summaries, and automated data extraction, enabling users to systematically organize information. By leveraging natural language processing algorithms, Iris.ai addresses the challenges of factuality tracking in AI, providing tools that enhance the accuracy and reliability of scientific research. This platform is aimed at both corporate R&D teams and academic researchers, allowing them to uncover new scientific insights that go beyond traditional human capabilities.

iLoF, or Intelligent Lab on Fiber, is a developer of a digital health platform that utilizes advanced photonics and artificial intelligence to enhance personalized drug discovery and development. The company has created a patented system that identifies and captures unique features of gold-standard biomarkers, compiling this information into a cloud-based library. By leveraging this extensive database, iLoF aims to facilitate collaboration among physicists, biologists, and data scientists, ultimately improving the efficiency and patient-centricity of clinical trials. This innovative approach not only reduces the costs associated with drug development but also aims to provide patients with tailored, life-saving treatments.

Arctic Therapeutics is a drug discovery and development company focused on identifying the genetic underpinnings of various diseases, both rare and common. Utilizing bioinformatic approaches and artificial intelligence, the company aims to mitigate the significant risks and high costs associated with traditional drug development, thereby accelerating the process of bringing effective treatments to patients. Collaborating with The Center for Applied Genomics at the Children’s Hospital of Philadelphia, Arctic Therapeutics is engaged in repurposing and developing innovative medical treatments. The company’s pipeline, which includes a promising Alzheimer's drug candidate, is conservatively valued at over $100 billion, with the potential not only to treat dementia but also to prevent it. Arctic Therapeutics was founded by Dr. Hakon Hakonarson, a leading figure in applied genomics, known for his substantial contributions to the field, including the establishment of the largest pediatric biobank and genomic database globally. Dr. Hakonarson has received significant recognition for his research, which includes breakthroughs in autism genetics and precision-based therapies.

Arctic Therapeutics is a drug discovery and development company focused on identifying the genetic underpinnings of various diseases, both rare and common. Utilizing bioinformatic approaches and artificial intelligence, the company aims to mitigate the significant risks and high costs associated with traditional drug development, thereby accelerating the process of bringing effective treatments to patients. Collaborating with The Center for Applied Genomics at the Children’s Hospital of Philadelphia, Arctic Therapeutics is engaged in repurposing and developing innovative medical treatments. The company’s pipeline, which includes a promising Alzheimer's drug candidate, is conservatively valued at over $100 billion, with the potential not only to treat dementia but also to prevent it. Arctic Therapeutics was founded by Dr. Hakon Hakonarson, a leading figure in applied genomics, known for his substantial contributions to the field, including the establishment of the largest pediatric biobank and genomic database globally. Dr. Hakonarson has received significant recognition for his research, which includes breakthroughs in autism genetics and precision-based therapies.

Energy Dome is an Italian company based in Lonate Pozzolo that specializes in long-duration electricity storage using liquid carbon dioxide. The company has developed a low-cost and efficient technology that employs a closed-loop thermodynamic process to store energy, making renewable power more dispatchable. By focusing on energy storage solutions, Energy Dome aims to facilitate the transition to renewable energy and contribute to the decarbonization of the energy industry. Its innovative approach seeks to address climate change challenges by significantly reducing greenhouse gas emissions, thereby promoting a more sustainable future.

FreezeM is focused on advancing preservation technologies that enhance the use of insects as a sustainable protein source for the animal feed industry. The company is developing innovative methods for large-scale freezing of insects, which will facilitate the creation of global stocks of frozen insect neonates and eggs. This approach aims to address critical challenges related to the availability, cost, and regulatory hurdles associated with utilizing insects in animal feed. By ensuring a stable and year-round production of these beneficial insects, FreezeM seeks to make a significant impact on the animal feed market, while also contributing to biological pest control and species preservation.

Blue Planet Ecosystems Incorporated, founded in 2018 and based in San Francisco, California, specializes in the development and operation of modular closed-loop photoprotein reactors that facilitate sustainable food production, particularly seafood, in extreme environments. The company's innovative technology mimics natural aquatic ecosystems, allowing for the conversion of sunlight and carbon dioxide into essential nutrients such as sugars, amino acids, and fatty acids. This process supports the production of organic seafood close to consumers, promoting a more efficient and environmentally friendly approach to aquaculture. By enabling farmers and agricultural businesses to diversify their methods, Blue Planet Ecosystems aims to address the challenges posed by climate change and enhance food security.

Kern Tec specializes in upcycling fruit kernels from stone fruits, specifically cherries, apricots, and plums, to create innovative food products. The company refines these kernels into high-quality raw materials suitable for various applications, including baking ingredients, sustainable cosmetic oils, fertilizers, and biomass. By focusing on environmentally friendly processes, Kern Tec provides clients in the baking, food supplement, dairy alternatives, and confectionery industries with naturally sourced materials, promoting sustainability while meeting industry demands.

Dxcover is a clinical-stage liquid biopsy company based in Glasgow, founded in 2016 by David S Palmer, Holly Butler, and Matthew Baker. The firm focuses on developing innovative diagnostics for the early detection of various cancers, which is crucial for improving treatment outcomes. Dxcover has pioneered the use of infrared spectroscopy combined with artificial intelligence to analyze circulating pan-omic indicators, allowing for the identification of cancer from a simple blood sample. This approach enables same-day diagnosis and patient stratification, facilitating timely interventions. The company has demonstrated strong clinical data supporting the accurate diagnosis of Stage I and Stage II cancers, underscoring its commitment to enhancing survival rates and quality of life for patients.

Sonio is an AI-based support platform for fetal ultrasound, helping practitioners analyze and diagnose congenital malformations. Sonio combines the patient’s medical history, genetic and biological data, and ultrasound semiology to assist physicians on the path to the right diagnosis. It assists sonographers during prenatal screening scans, helping them ensure that they have not forgotten anything, take risk factors into account, and facilitate the sharing of images with patients and other health professionals.

Releaf Paper is a producer of sustainable paper products that utilizes fallen leaves as a raw material, aiming to reduce the environmental impact associated with traditional paper production. By sourcing leaves from city parks and other urban areas, Releaf Paper offers an innovative alternative to wood-based paper. Their technology not only addresses sustainability concerns but also minimizes water and energy consumption in the manufacturing process. This approach enables paper manufacturers to adopt more environmentally friendly practices while contributing to a circular economy.

iOnctura is a biopharmaceutical company that develops novel therapeutics aimed at addressing immunosuppression within the tumor microenvironment, which can hinder effective cancer treatment. The company focuses on creating next-generation biomolecules to enhance existing immune checkpoint therapies, ultimately aiming to improve patient outcomes in cancer treatment. Through collaborations with Merck and Cancer Research Technology, iOnctura is advancing a pipeline of preclinical molecules designed to be used in combination with immuno-oncology therapies. With access to state-of-the-art drug discovery laboratories and a network of academic partners, iOnctura is strategically positioned to develop innovative combination therapies in cancer immunology, ensuring a focused approach to tackling the complexities of cancer and fibrosis.

Water Challenge is a company that provides a disruptive solution based on an economically sustainable technology that allows the treatment of any type of contaminated fluid, extracting all the solids contained, crystallizing, and purifying water suitable for human consumption, irrigation, and other uses.

Nano4Imaging GmbH, founded in 2011 and based in Aachen, Germany, specializes in the development and production of contrast agents and devices designed for in-vivo imaging of medical implants and minimal invasive devices, such as catheters and guidewires. The company offers products like MRWire EmeryGlide, a guide wire compatible with magnetic resonance imaging (MRI), and the MagnaFy series, which includes coatings that enhance visibility under MRI, computed tomography (CT), and X-ray imaging. These innovations facilitate medical interventions and therapies, particularly in the treatment of cardiovascular diseases and during radiotherapy, allowing for precise monitoring of medical devices during procedures. By leveraging nanotechnology, Nano4Imaging aims to enhance diagnostic imaging capabilities for healthcare professionals.

ValueBiotech Srl is a medical device company focused on developing robotic surgical tools that enhance laparoscopic techniques. Designed by practicing surgeons, these innovative tools integrate seamlessly into operating rooms, enabling surgeons to perform procedures through a single incision or natural orifices, resulting in a painless and scarless experience for patients. The company's mission is to improve clinical outcomes while ensuring safety and cost-effectiveness in surgical practices. By transforming traditional surgical methods, ValueBiotech aims to provide better healthcare solutions for millions of patients each year.

AVATAR MEDICAL specializes in developing a virtual reality platform that creates 3D patient avatars from medical images. This innovative technology assists surgeons in visualizing complex medical data, evaluating surgical options, and enhancing training for medical fellows. By providing accurate and interactive representations of patients, the platform enables clinicians to better comprehend critical clinical information, ultimately improving the decision-making process in surgical planning. Additionally, AVATAR MEDICAL's approach fosters greater engagement with patients, allowing them to better understand their medical conditions and treatment options.

Alesi Surgical Ltd. specializes in the development and commercialization of laparoscopic surgical smoke handling systems aimed at enhancing the safety and outcomes of surgical procedures. Founded in 2009 and based in Cardiff, United Kingdom, the company emerged as a spin-out from the Welsh Institute for Minimal Access Therapy, benefiting from direct access to experienced surgeons and surgical trainers. Alesi Surgical's innovative products are designed to be portable and applicable in both laparoscopic and robot-assisted surgeries. Utilizing electrostatic precipitation technology, these tools effectively eliminate surgical smoke, ensuring a clear visual field during procedures. Alesi Surgical distributes its products to hospitals across Europe, the Middle East, New Zealand, and Australia.

Skyfora is a company focused on enhancing weather observation and forecasting through innovative technology. It addresses the limitations of traditional weather data by utilizing patented GNSS Meteorology solutions and AI-enhanced forecasting methods. By repurposing GNSS receivers from telecom base stations, Skyfora transforms them into advanced 4D weather scanners, significantly increasing the volume of weather observation data generated from existing infrastructure. This innovative approach not only improves the performance of AI-driven weather forecasts but also contributes to global sustainability and climate change resilience. In addition, Skyfora develops forecasting software that leverages computer vision and IoT technologies to analyze satellite images, enhancing the scientific understanding of hurricanes and aiding disaster management efforts. This combination of advanced technology and sustainable practices positions Skyfora as a leader in the field of weather forecasting and climate resilience.

Herantis Pharma is a biotechnology company focused on addressing unmet clinical needs through the development of disease-modifying therapies for Parkinson's disease. The company's primary development program centers on HER-096, a peptidomimetic molecule engineered to preserve the biological activity of the neuroprotective CDNF protein. By targeting the underlying mechanisms of the disease, Herantis Pharma aims to provide innovative treatment options for patients suffering from Parkinson's disease.

Vaultree is a data enablement company that specializes in encryption solutions, addressing the challenges associated with using decrypted data. The company has pioneered Data-In-Use Encryption, utilizing advanced technologies like Fully Homomorphic Encryption (FHE) to allow data to remain encrypted during processing. This innovation enables businesses to perform in-use encrypted searches, analyses, sharing, collaboration, AI/ML modeling, and data visualization, all while keeping the data secure. Vaultree's encryption-as-a-service platform is designed to protect sensitive information, facilitating seamless operations for businesses of all sizes and supporting growth and cost reduction through enhanced data privacy and security.

ALA Diagnostics specializes in the development and marketing of in vitro diagnostic kits aimed at addressing high-prevalence pathologies and unmet medical needs. The company focuses particularly on multiple sclerosis, offering diagnostic kits that facilitate early diagnosis of the condition. These kits are designed for seamless integration into the clinical routines of hospitals and medical centers, enabling healthcare professionals to deliver accurate results. By improving diagnostic capabilities, ALA Diagnostics aims to enhance the quality of life for individuals affected by multiple sclerosis. The company leverages collaborations with public organizations to foster innovative projects and enhance its product offerings.

inPhocal is a company that specializes in advanced laser processing technology, utilizing a unique laser beam system originally developed from CERN research. The firm focuses on specialized printing solutions, offering undeletable prints for critical applications such as expiration dates and batch codes. Their innovative marking printer operates without ink, providing a faster alternative to traditional marking machines while maintaining high-quality prints on uneven surfaces. This technology aims to enhance current optical printing methods, positioning inPhocal as a leader in the field of laser processing.

Afon Technology specializes in developing non-invasive blood glucose monitoring devices aimed at improving the management of diabetes. Their innovative technology allows users to convert any smartwatch into a glucose monitoring device that provides real-time tracking of blood glucose levels, including high and low alerts. The devices offer fast and accurate measurements, data logging, and personalized health trend analysis, which help users monitor their condition effectively. Additionally, Afon Technology's solutions feature Bluetooth connectivity to smart devices, enabling compatibility with both iOS and Android platforms. This user-friendly approach enhances the quality of daily diabetes management and helps reduce the risk of complications associated with the condition.

Deep Render Ltd. is a London-based AI start-up that originated from the Department of Computing at Imperial College London. The company specializes in developing advanced media compression algorithms using proprietary and patented technology grounded in machine learning research. Its innovative approach focuses on deep learning, density estimation, and unsupervised learning, resulting in state-of-the-art Biological Image Compression that offers at least a 50% efficiency gain over existing standards. Deep Render's technology is notable for being the first AI-based codec capable of real-time video playback, allowing for significant market expansion and cost reduction for users.

DeepOpinion is a cognitive automation platform designed for businesses to streamline operations and enhance productivity by automating repetitive processes involving unstructured data. The platform features a no-code interface that allows users to quickly create automation workflows, supporting various industries in their efforts to improve efficiency. Utilizing a proprietary auto-machine learning engine, DeepOpinion enables developers and data scientists to employ advanced deep learning technology for natural language processing (NLP) models. Its intelligent process capabilities facilitate the decoding of human opinions into actionable insights, making it easier for clients to automate text-based tasks through a user-friendly drag-and-drop workflow builder.

Vésale Pharma is a company dedicated to producing pharmaceutical products that aim to enhance health and well-being for individuals throughout their lives. Collaborating with internationally recognized research organizations, Vésale Pharma focuses on developing innovative healthcare solutions tailored to diverse needs. Their product range addresses various health concerns, including dermatology, gastroenterology, women's health, immunity, and pregnancy. Notably, the company's offerings are designed to have no side effects and are suitable for all body types, ensuring that patients can maintain their fitness and overall health.

Reverion specializes in developing reversible, carbon-negative power plants that leverage patented technology to maximize the potential of biogas. The company's containerized units, designed for mass production, achieve remarkable electrical efficiencies of 80% for both power generation and energy storage. This innovative approach not only doubles the electricity output of traditional gas engines but also significantly reduces greenhouse gas emissions, resulting in a negative CO2 balance. Additionally, Reverion's technology is capable of utilizing excess solar and wind power, enhancing electricity production in existing biogas plants and stabilizing the power grid during electrolysis. Through these advancements, Reverion aims to promote a renewable and decarbonized energy future.